GB Patent

GB9523752D0 — Pharmaceutical formulations

Assigned to Pfizer Ltd Great Britain · Expires 1996-01-24 · 30y expired

What this patent protects

Patent listed against Myrbetriq.

Drugs covered by this patent

Myrbetriq (MIRABEGRON) · Apgdi

Patent Metadata

Patent number: GB9523752D0
Jurisdiction: GB
Classification: —
Expires: 1996-01-24
Drug substance claim: No
Drug product claim: No
Assignee: Pfizer Ltd Great Britain
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.